Abstract
The clinical effects of Cerocral were studied on 16 patients with peripheral vertigo principally Meniere's disease, and these effects were assessed by subjective and objective parameters. The results obtained were as follows;
(1) Cerocral was effective in 80% of patients.
(2) As to the subjective symptoms, the frequency and intensity of vertigo and nausea and/or vomitting were prominently improved, and tinnitus, headache and shoulder stiffness were comparatively improved.
(3) As to the objective parameters, the stepping test and positional nystagmus test were also prominently improved.
(4) No sereous side-effects were observed.
Thus, Cerocral seemed to be effective and safe for treatment of peripheral vertigo.
